Drugs Health Medical

Salt substitutes effective in reducing hypertension in elderly people

HQ Team February 13, 2024: Adding to the long line of evidence that reducing salt intake affects blood pressure is the latest study.

Read More
Drugs Medical Pharma

Gilead buys CymaBay for $ 4.3b to expand its liver portfolio

HQ Team February 13, 2024: Gilead Sciences is buying CymaBay Therapeutics for $4.3 billion, to access its portfolio of drugs for liver and.

Read More
Drugs Health Pharma

People with severe depressive disorder have higher body temperature

 HQ Team February 12, 2024: People with depression may have higher body temperatures and lowering the heat is likely to be beneficial to.

Read More
Drugs Health Pharma

Researchers find five cases of medically-acquired Alzheimer’s in UK

HQ Team February 12, 2024: Scientists have discovered five known cases of possible medically acquired Alzheimer’s disease after the patients have undergone previous.

Read More
Drugs Health Medical

New research points at higher incidence of long COVID in children

HQ Team February 9, 2024: The coronavirus may have lost its virulence with time but its long-term effects are still being revealed among.

Read More
Drugs Health Pharma

A new oral drug may stop triple-negative breast cancer in its tracks

HQ Team February 8, 2024: Australian scientists may have found a drug to treat triple-negative breast cancer without any toxic effects, according to.

Read More
Drugs Health Pharma

Gilead Sciences puts last-stage blood cancer trials on hold after FDA order

HQ Team February 8, 2024: Gilead Sciences, Inc., announced it has discontinued trials on a drug to treat blood cancer after the US.

Read More
Drugs Health Medical

Global cancer cases set to surge by 77% by 2050, new report warns

HQ Team February 6, 2024: A projection from the Global Cancer Observatory suggests that new cancer cases worldwide are set to surge by.

Read More
Drugs Medical Pharma

‘Pharma firms manipulate patents to curb competition and drive prices’

A study conducted by researchers from Harvard University has revealed a concerning trend within the pharmaceutical industry— the widespread adoption of intricate patent.

Read More
Drugs Health Pharma

Novartis to buy MorphoSys for $2.9 billion to expand cancer portfolio

HQ Team February 6, 2024: Novartis AG is set to buy a German-based biotechnology company, MorphoSys AG, for $2.9 billion, giving the Swiss.

Read More